Pfizer (PFE)

Investors are running into Viking Therapeutics this week after an incident of drug-induced liver injury pushed Pfizer into terminating the development of its weight-loss pill.

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active S&P500 stocks in today's session.

Novavax updated Covid vaccine showed fewer and milder side effects than Pfizer-BioNTech's in a Utah study.

Investors are now considering the possibility of Pfizer acquiring either of these companies as it looks for external candidates.

Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation, Chevron Corporation, and Stryker Corporation, as well as two micro-cap stocks, Value Line, Inc. and Sypris Solutions, Inc.

Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session.

Stocks are firmly higher Monday, as a surprise tariff exemption from President Donald Trump sparked a rally in the tech sector.

The company said the seized counterfeit products feature lot number PAR0362 and illegitimate serial numbers beginning with the first eight digits, 51746517.

Pfizer bows, but is not entirely out of the GLP-1 race.

Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesity drug competition.

The social media giant acquired Instagram in 2012 for $1 billion and WhatsApp in a highly competitive bid in 2014 for a whopping $19 billion, beating Google to the punch.

A groundbreaking study published in the International Journal of Cardiovascular Research & Innovation reveals alarming long-term heart risks linked to COVID-19 mRNA vaccines, challenging official narratives and raising urgent safety concerns. Contact: Lynne@imahealth.org

Pfizer has ended development of danuglipron, an oral GLP-1 drug for weight management, citing clinical data and regulatory input.

Baristas must wear a solid black top and a denim bottom in any shade of khaki, blue, or black.

The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at its annual meeting of stockholders on June 5.

According to Pfizer, the reported patient’s liver enzymes “recovered rapidly” after they stopped taking the company’s experimental weight loss pill.

The company is continuing to test a daily pill that blocks GIPR.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Friday. Discover the stocks that are generating the highest trading volume and driving market activity.

Massive container ports and supply chains worldwide are bracing for impact as broad U.S. import tariffs reshape commerce.

Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs.